Computed tomography imaging of cardiac allograft vasculopathy

Maros Ferencik, Thomas J. Brady, Udo Hoffmann

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Cardiac allograft vasculopathy (CAV) is the main cause of morbidity and mortality beyond 1 year after heart transplantation. Ischemic symptoms are usually not present because of the denervated allograft and diffuse nature of the disease. Patients present with heart failure, ventricular arrhythmia, or sudden cardiac death as a result of advanced CAV. Therefore, clinical evaluation includes routine annual invasive coronary angiography (ICA) and transthoracic echocardiography to screen for CAV. Noninvasive imaging methods for the detection of CAV have not been widely adopted. Computed tomography (CT) permits detection of coronary stenoses and plaque in the nontransplant population. The strength of CT is its high negative predictive value. These attributes predispose CT to a role of a gatekeeper for further invasive testing in heart transplant recipients. We reviewed the available literature on CT evaluation of CAV. Technical challenges (eg, high heart rates, need for contrast and radiation, image quality) specific for patients who have received a heart transplant are emphasized, and solutions, including appropriate protocols and advances through the new CT technology, are summarized. We systematically analyze the results of studies that report the diagnostic performance of cardiac CT for the detection of coronary stenoses compared with ICA. Similar analysis is performed for the comparison between CT and intravascular ultrasound scanning for the detection of nonobstructive CAV. Finally, we suggest future directions in cardiac CT imaging research of CAV.

Original languageEnglish (US)
Pages (from-to)223-231
Number of pages9
JournalJournal of Cardiovascular Computed Tomography
Volume6
Issue number4
DOIs
StatePublished - Jul 2012
Externally publishedYes

Fingerprint

Allografts
Tomography
Coronary Stenosis
Coronary Angiography
Sudden Cardiac Death
Heart Transplantation
Echocardiography
Cardiac Arrhythmias
Heart Failure
Heart Rate
Radiation
Technology
Morbidity
Transplants
Mortality
Research
Population

Keywords

  • Cardiac allograft vasculopathy
  • Cardiac computed tomography
  • Coronary computed tomography angiography
  • Heart transplantation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Computed tomography imaging of cardiac allograft vasculopathy. / Ferencik, Maros; Brady, Thomas J.; Hoffmann, Udo.

In: Journal of Cardiovascular Computed Tomography, Vol. 6, No. 4, 07.2012, p. 223-231.

Research output: Contribution to journalArticle

Ferencik, Maros ; Brady, Thomas J. ; Hoffmann, Udo. / Computed tomography imaging of cardiac allograft vasculopathy. In: Journal of Cardiovascular Computed Tomography. 2012 ; Vol. 6, No. 4. pp. 223-231.
@article{75549c3ab3744dabafd2339915c7c131,
title = "Computed tomography imaging of cardiac allograft vasculopathy",
abstract = "Cardiac allograft vasculopathy (CAV) is the main cause of morbidity and mortality beyond 1 year after heart transplantation. Ischemic symptoms are usually not present because of the denervated allograft and diffuse nature of the disease. Patients present with heart failure, ventricular arrhythmia, or sudden cardiac death as a result of advanced CAV. Therefore, clinical evaluation includes routine annual invasive coronary angiography (ICA) and transthoracic echocardiography to screen for CAV. Noninvasive imaging methods for the detection of CAV have not been widely adopted. Computed tomography (CT) permits detection of coronary stenoses and plaque in the nontransplant population. The strength of CT is its high negative predictive value. These attributes predispose CT to a role of a gatekeeper for further invasive testing in heart transplant recipients. We reviewed the available literature on CT evaluation of CAV. Technical challenges (eg, high heart rates, need for contrast and radiation, image quality) specific for patients who have received a heart transplant are emphasized, and solutions, including appropriate protocols and advances through the new CT technology, are summarized. We systematically analyze the results of studies that report the diagnostic performance of cardiac CT for the detection of coronary stenoses compared with ICA. Similar analysis is performed for the comparison between CT and intravascular ultrasound scanning for the detection of nonobstructive CAV. Finally, we suggest future directions in cardiac CT imaging research of CAV.",
keywords = "Cardiac allograft vasculopathy, Cardiac computed tomography, Coronary computed tomography angiography, Heart transplantation",
author = "Maros Ferencik and Brady, {Thomas J.} and Udo Hoffmann",
year = "2012",
month = "7",
doi = "10.1016/j.jcct.2011.11.007",
language = "English (US)",
volume = "6",
pages = "223--231",
journal = "Journal of Cardiovascular Computed Tomography",
issn = "1934-5925",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Computed tomography imaging of cardiac allograft vasculopathy

AU - Ferencik, Maros

AU - Brady, Thomas J.

AU - Hoffmann, Udo

PY - 2012/7

Y1 - 2012/7

N2 - Cardiac allograft vasculopathy (CAV) is the main cause of morbidity and mortality beyond 1 year after heart transplantation. Ischemic symptoms are usually not present because of the denervated allograft and diffuse nature of the disease. Patients present with heart failure, ventricular arrhythmia, or sudden cardiac death as a result of advanced CAV. Therefore, clinical evaluation includes routine annual invasive coronary angiography (ICA) and transthoracic echocardiography to screen for CAV. Noninvasive imaging methods for the detection of CAV have not been widely adopted. Computed tomography (CT) permits detection of coronary stenoses and plaque in the nontransplant population. The strength of CT is its high negative predictive value. These attributes predispose CT to a role of a gatekeeper for further invasive testing in heart transplant recipients. We reviewed the available literature on CT evaluation of CAV. Technical challenges (eg, high heart rates, need for contrast and radiation, image quality) specific for patients who have received a heart transplant are emphasized, and solutions, including appropriate protocols and advances through the new CT technology, are summarized. We systematically analyze the results of studies that report the diagnostic performance of cardiac CT for the detection of coronary stenoses compared with ICA. Similar analysis is performed for the comparison between CT and intravascular ultrasound scanning for the detection of nonobstructive CAV. Finally, we suggest future directions in cardiac CT imaging research of CAV.

AB - Cardiac allograft vasculopathy (CAV) is the main cause of morbidity and mortality beyond 1 year after heart transplantation. Ischemic symptoms are usually not present because of the denervated allograft and diffuse nature of the disease. Patients present with heart failure, ventricular arrhythmia, or sudden cardiac death as a result of advanced CAV. Therefore, clinical evaluation includes routine annual invasive coronary angiography (ICA) and transthoracic echocardiography to screen for CAV. Noninvasive imaging methods for the detection of CAV have not been widely adopted. Computed tomography (CT) permits detection of coronary stenoses and plaque in the nontransplant population. The strength of CT is its high negative predictive value. These attributes predispose CT to a role of a gatekeeper for further invasive testing in heart transplant recipients. We reviewed the available literature on CT evaluation of CAV. Technical challenges (eg, high heart rates, need for contrast and radiation, image quality) specific for patients who have received a heart transplant are emphasized, and solutions, including appropriate protocols and advances through the new CT technology, are summarized. We systematically analyze the results of studies that report the diagnostic performance of cardiac CT for the detection of coronary stenoses compared with ICA. Similar analysis is performed for the comparison between CT and intravascular ultrasound scanning for the detection of nonobstructive CAV. Finally, we suggest future directions in cardiac CT imaging research of CAV.

KW - Cardiac allograft vasculopathy

KW - Cardiac computed tomography

KW - Coronary computed tomography angiography

KW - Heart transplantation

UR - http://www.scopus.com/inward/record.url?scp=84862738127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862738127&partnerID=8YFLogxK

U2 - 10.1016/j.jcct.2011.11.007

DO - 10.1016/j.jcct.2011.11.007

M3 - Article

C2 - 22732195

AN - SCOPUS:84862738127

VL - 6

SP - 223

EP - 231

JO - Journal of Cardiovascular Computed Tomography

JF - Journal of Cardiovascular Computed Tomography

SN - 1934-5925

IS - 4

ER -